Hyperexpression of inducible costimulator on lamina propria mononuclear cells in rat dextran sulfate sodium colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 19, Issue 2, 2004, Pages 174-181

  Ishii, Kenichi ^a   Kanai, Takanori ^a   Totsuka, Teruji ^a   Uraushihara, Koji ^a   Ishikura, Takahiro ^a   Yamazaki, Motomi ^a   Okamoto, Ryoici ^a   Araki, Akihiro ^a   Miyata, Tatsuya ^a   Tezuka, Katsuaki ^b   Nakamura, Tetsuya ^a   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Pharmaceutical Frontier Research Laboratory   (Japan)

Author keywords

CD28; Costimulation; Crohn's disease; Inducible costimulator; Ulcerative colitis

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CONCANAVALIN A; DEXTRAN SULFATE; INDUCIBLE COSTIMULATOR; INDUCIBLE COSTIMULATOR MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL LEVEL; CHRONIC DISEASE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MESENTERY LYMPH NODE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; SPECIES COMPARISON; SPLEEN; SPLEEN CELL; T LYMPHOCYTE; THYMUS; UPREGULATION;

EID: 10744229101     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2004.03202.x     Document Type: Article

References (35)

1. Podolsky DK. Inflammatory bowel disease (first of two). N. Engl. J. Med. 1995; 325: 928-37.
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
3. Fuss IJ, Neurath M, Boirvant M et al. Disparate CD4+ lamina propria (LP) lymphokine secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 1996; 157: 1261-70.
4. Parronchi P, Romagnani P, Annuziato F et al. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. Am. J. Pathol. 1997; 150: 823-32.
5. Hammer RE, Maika SD, Richardson JA, Tang YP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human b2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112.
6. Watanabe M, Ueno Y, Yajima T et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 1998; 187: 389-402.
7. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horvak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993; 75: 253-61.
8. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
9. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bahn AK, Tonegawa S, Spontaneous development of inflammatory bowel disease in T-cell receptor mutant mice. Cell 1993; 75: 275-82.
10. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45Rbhi CD4+ T-cells. Immunity 1994; 1: 553-62.
11. Okayasu I, Hatakeyama S, Ohkusa T et al. A novel method in the induction of reliable experimental acute and chronic ulcereactive colitis in mice. Gastroenterology 1990; 98: 694-702.
12. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol. Today 1994; 15: 321-31.
13. Chambers CA. The expanding world of co-stimulation: the two-signal model revised. Trends Immunol. 2001; 22: 217-23.
14. Coyle AJ, Gutierrez-Ramos JC. The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T-cell function. Nat. Immunol. 2001; 2: 203-9.
15. Perrin PJ, June CH, Maldonado JH, Ratts RB, Racke MK. Blockade of CD28 during in vitro activation of encephalitogenic T-cells or after disease onset ameliorates experimental autoimmune encephalomyelitis. J. Immunol. 1999; 163: 1704-10.
16. Tada Y, Nagasawa K, Ho A et al. CD28-deficient mice are highly resistant to collagen-induced arthritis. J. Immunol. 1999; 162: 203-8.
17. Hutloff A, Dittrich AM, Beier KC, Eijaschewitsch B, Kraft R, Kroczek RA. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28. Nature 1999; 397: 263-6.
18. Tamatani T, Tezuka K, Hanzawa-Higuchi N. AILIM/ICOS: a novel lymphocyte adhesion molecule. Int. Immunol. 2000; 12: 51-5.
19. Yoshinaga SK, Whoriskey JS, Khare SD et al. T-cell costimulation through B7RP-1 and ICOS. Nature 1999; 402: 827-32.
20. Swallow MM, Wallin II, Sha WC. B7h, a novel costimulatory homolog of B7. 1 and B7.2, is induced by TNF-α. Immunity 1999; 11: 423-32.
21. Ling V, Wu PW, Finnerty HF et al. Cutting edge identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 2000; 164: 1653-7.
22. Ishikawa Nagase T, Suyama M, Miyajima N et al. Prediction of the coding sequence of unidentified human genes. X. The complex sequences of 100 new cDNA clones from brain which can code for large proteins in vitro. DNA Res. 1998; 5: 169-76.
23. Wang S, Zhu G, Chapoval AI et al. Costimulation of T-cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000; 96: 2808-13.
24. Brodie D, Collins AV, Iaboni A et al. LICOS, a primordial costimator ligand? Curr. Biol. 2000; 10: 333-6.
25. Dong C, Juedes AE, Tamann UA et al. ICOS costimulatory receptor is essential for T-cell activation and function. Nature 2001; 409: 97-101.
26. Tafuri A, Shahinian A, Bladt F et al. ICOS is essential for effective T-helper-cell responses. Nature 2001; 409: 105-9.
27. Ozkaynak E, Gao W, Shemmeri N et al. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat. Immunol. 2001; 2: 591-6.
28. Rottman JB, Smith T, Tonra JR et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2001; 2: 605-11.
29. Totsuka T, Kanai T, Iiyama R et al. Ameliorating effect of anti-inducible costimulator monoclonal antibody in a murine model of chronic colitis. Gastroenterology 2003; 124: 410-21.
30. Sakamoto S, Tezuka K, Tsuji T, Hori N, Tamatani T. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies. Hybrid Hybridomics 2001; 20: 293-303.
31. Lugea A, Salas A, Casalot J, Guarner F, Malagelada J-R. Surface hydrophobicity of the rat colonic mucosa is a defensive barrier against macromolecules and toxins. Gut 2000; 46: 515-21.
32. Beier KC et al. Induction, binding specificity and function of human ICOS. Eur. J. Immunol. 2000; 30: 3707-17.
33. Mages HW et al Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur. J. Immunol. 2000; 30: 1040-7.
34. MacLennan IC. Germinal centers. Annu. Rev. Immunol. 1994; 12: 117-39.
35. Tsiagbe VK, Inghirami G, Thorbecke GJ. The physiology of germinal centers. Crit. Rev. Immunol. 1996; 16: 381-421.